iqvia weight loss prescriptions semaglutide tirzepatide q3 2024 Eli Lilly Stock Will 'Dominate' GLP-1 Market in With Zepbound Business | Novo Nordisk has

Proper hydration is essential for maintaining energy levels and overall well-being

Microdosing tirzepatide schedule: How to microdose tirzepatide As microdosing is an experimental and off-label practice, currently, there is no data or recommendations on tirzepatide dosage

News The TGA has received 44 reports linked to the drug, but one GP says a spike in concern may not be mentioning high-quality evidence

S., Kraft, G

A.Koivisto HurstiU.-K.LarssonM

Q2 2025 Snapshot Eli Lilly and Company dominates the US 57 % GLP-1 share, led by Mounjaro (tirzepatide) HCP & Zepbound (tirzepatide) HCP Novo Nordisk rules Europe 63 % value share, powered by Wegovy(semaglutide) injection 2.4 mg HCP & Ozempic APAC & Emerging Markets are the next frontier (+1113 % YoY) Together, they crossed $24 Billion in H1 2025 GLP-1 revenue proving the real blockbuster of this decade isnt oncology or immunology Its metabolic health